BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9188761)

  • 1. Effect of acute hyperglycemia on basal and cholecystokinin stimulated exocrine pancreatic secretion in humans.
    Lam WF; Masclee AA; de Boer SY; Souverijn JH; Lamers CB
    Life Sci; 1997; 60(24):2183-90. PubMed ID: 9188761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of acute hyperglycemia on basal, secretin and secretin + cholecystokinin stimulated exocrine pancreatic secretion in humans.
    Lam WF; Masclee AA; Souverijn JH; Lamers CB
    Life Sci; 1999; 64(8):617-26. PubMed ID: 10069525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of acute hyperglycemia on basal and bombesin-stimulated pancreaticobiliary secretion in humans.
    Lam WF; Masclee AA; Muller ES; Souverijn JH; Lamers CB
    Pancreas; 1998 Aug; 17(2):201-7. PubMed ID: 9700954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of acute hyperglycaemia on basal and fat-induced exocrine pancreatic secretion in humans.
    Lam WF; Muller ES; Souverijn JH; Lamers CB; Masclee AA
    Clin Sci (Lond); 1997 Dec; 93(6):573-80. PubMed ID: 9497795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of insulin and glucose on basal and cholecystokinin-stimulated exocrine pancreatic secretion in humans.
    Lam WF; Gielkens HA; Coenraad M; Souverijn JH; Lamers CB; Masclee AA
    Pancreas; 1999 Apr; 18(3):252-8. PubMed ID: 10206483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperglycemia reduces pancreaticobiliary secretion in response to modified sham feeding in humans.
    Lam WF; Lindeboom ME; Lamers CB; Masclee AA
    Digestion; 1999; 60(2):141-6. PubMed ID: 10095155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of peptide YY on pancreatico-biliary secretion in humans.
    Symersky T; Biemond I; Frolich M; Masclee A
    Scand J Gastroenterol; 2005 Aug; 40(8):944-9. PubMed ID: 16173137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of cholecystokinin-stimulated pancreaticobiliary output in man by the cholecystokinin receptor antagonist MK-329.
    Cantor P; Olsen O; Gertz BJ; Gjorup I; Worning H
    Scand J Gastroenterol; 1991 Jun; 26(6):627-37. PubMed ID: 1713709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of intravenous glucose on intravenous amino acid-induced gallbladder contraction and CCK secretion.
    De Boer SY; Masclee AA; Lam WF; Jansen JB; Lamers CB
    Dig Dis Sci; 1994 Feb; 39(2):268-74. PubMed ID: 8313807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The significance of plasma CCK and secretin in the oleate-stimulated pancreatico-biliary secretion in man.
    Olsen O; Schaffalitzky de Muckadell OB; Cantor P
    Int J Pancreatol; 1986 Dec; 1(5-6):363-72. PubMed ID: 2445869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the specific cholecystokinin-receptor antagonist loxiglumide on bombesin stimulated pancreatic enzyme secretion in man.
    Jebbink MC; Jansen JB; Mooy DM; Rovati LC; Lamers CB
    Regul Pept; 1991 Feb; 32(3):361-8. PubMed ID: 1714084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of insulin on basal and cholecystokinin-stimulated gallbladder motility in humans.
    Gielkens HA; Lam WF; Coenraad M; Frölich M; van Oostayen JA; Lamers CB; Masclee AA
    J Hepatol; 1998 Apr; 28(4):595-602. PubMed ID: 9566827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of pancreatic polypeptide on insulin action in exocrine secretion of isolated rat pancreas.
    Park HJ; Lee YL; Kwon HY
    J Physiol; 1993 Apr; 463():421-9. PubMed ID: 7504106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of hyperglycemia on the satiating effect of CCK in humans.
    Lam WF; Gielkens HA; de Boer SY; Lamers CB; Masclee AA
    Physiol Behav; 1998 Dec; 65(3):505-11. PubMed ID: 9877417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperglycemia modulates gallbladder motility and small intestinal transit time in man.
    de Boer SY; Masclee AA; lam WF; Schipper J; Jansen JB; Lamers CB
    Dig Dis Sci; 1993 Dec; 38(12):2228-35. PubMed ID: 8261826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of acute hyperglycaemia on gall bladder contraction induced by cholecystokinin in humans.
    de Boer SY; Masclee AA; Jebbink MC; Schipper J; Lemkes HH; Jansen JB; Lamers CB
    Gut; 1993 Aug; 34(8):1128-32. PubMed ID: 8174967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperglycemia reduces gallbladder emptying and plasma hormone secretion to modified sham feeding and regular feeding.
    De Boer SY; Masclee AA; Lam WF; Schipper J; Jansen JB; Lamers CB
    Hepatology; 1993 Jun; 17(6):1022-7. PubMed ID: 8514250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physiological control of cholecystokinin release and pancreatic enzyme secretion by intraduodenal bile acids.
    Koop I; Schindler M; Bosshammer A; Scheibner J; Stange E; Koop H
    Gut; 1996 Nov; 39(5):661-7. PubMed ID: 9026479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of pancreatic polypeptide on the pancreatic exocrine secretion stimulated by secretin and cholecystokinin in the conscious pig.
    Langlois A; Corring T; Cuber JC; Gueugneau AM; Levenez F; Chayvialle JA
    Regul Pept; 1989 Jan; 24(1):55-65. PubMed ID: 2740529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancreatic growth after pancreatico-biliary diversion does not increase the capacity to secrete amylase.
    Axelson J; Jansen C; Sternby B; Björkman A; Rehfeld JF; Ihse I
    Eur Surg Res; 1999; 31(2):187-95. PubMed ID: 10213858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.